Necrotizing Fascitis
9
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions
Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling
FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).
Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections
The Management of Necrotizing Soft Tissue Infection Wounds With Cytal® Wound Matrix and MicroMatrix®
A Single-stage Bilayered Skin Reconstruction With Glyaderm®
VAC and Conventional Dressing in the Healing Process of Necrotizing Fasciitis
Compare Effects of Dressing With Honey and EUSOL
Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study